480

Compound name
Pyrotinib
Alt Name
SHR-1258
UNII-CJN36EQM0H
CJN36EQM0H
Compound Image
Pyrotinib.png
SMILES
CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)C=CC5CCCN5C
MW
583.10
Brutto
C32H31ClN6O3
InChI
InChI=1S/C32H31ClN6O3/c1-3-41-30-17-27-25(16-28(30)38-31(40)12-10-24-8-6-14-39(24)2)32(21(18-34)19-36-27)37-22-9-11-29(26(33)15-22)42-20-23-7-4-5-13-35-23/h4-5,7,9-13,15-17,19,24H,3,6,8,14,20H2,1-2H3,(H,36,37)(H,38,40)/b12-10+/t24-/m1/s1
InChI Key
SADXACCFNXBCFY-IYNHSRRRSA-N
Approval Jurisdiction
2020 China
Approved for clinical use
Breast Cancer
CAS
1269662-73-8
PubChem CID
51039030
Action
EGFR; HER2/4
Approved Drug List
1
Commercial Vendor
Jiangsu Hengrui